-
How rare is rare? Quantifying the hidden population living with rare genetic diseases using genetic databases
Rare Disease Day is fast approaching, with a programme of activity being lined up, through international initiatives and country-specific programmes, in the UK for example to highlight challenges, raise awareness and generate change for the 300 million people worldwide living with one or more of the roughly 8,000 known rare diseases, as well as their […]
-
Join us at upcoming conferences to discuss the latest findings in the epidemiology of rare diseases.
It’s a well-established truism that rare diseases, whilst rare at the individual disease level, are collectively quite common, with some 300 million people worldwide living with a rare disease. However, are rare diseases actually as rare at the individual disease level as current estimates suggest – what could be the extent of the “hidden population”? […]
-
Early intervention for preventing NCDs: generating evidence for the health and economic impact, using microsimulation modelling
Non-communicable diseases (NCDs), including heart disease, stroke, cancer, diabetes and chronic lung disease, are the leading causes of death worldwide. A recent report by FP Analytics sets out the scale of the problem and the health and economic burden of NCDs. These conditions share a common set of risk factors of which the main ones […]
-
NEWS: HealthLumen to participate in air pollution project funded by UK Research and Innovation (UKRI)
HealthLumen is part of a consortium that has been a awarded a £50,000 Fast Start: Innovation grant to undertake a pilot project in Sandwell to reduce poor air quality through community measures. Air pollution is a major environmental cause of early death: it is also responsible for short- and long-term respiratory conditions such as asthma and lung […]
-
Impactability Modelling for Population Health Management
We’re looking forward to attending the NHS Population Health conference on 2nd November which will bring together NHS professionals to discuss PHM strategies aimed at addressing the many pressing issues facing the NHS. Our COO and co-founder Laura Webber, will be giving a talk on Population Health Management of non-communicable diseases: measuring the impact of […]
-
Happy Birthday to us…
Today is a year since HealthLumen was founded. And, despite the current situation, we are fortunate that we have much to celebrate. To get the company launched we completed a successful transaction with the UK Health Forum, taking ownership of a powerful microsimulation platform with a 12-year track record of modelling non-communicable diseases and the […]
-
2020 Vision: And beyond
The term “20/20 vision” informally denotes perfect eyesight. So, moving into the year 2020 it is an apt metaphor for our goal, which is to help improve global population health through better decision-making. Our forecasting methodology – based on a microsimulation model – integrates health, economic and population data from multiple sources as a baseline […]
